Table 1 Characteristics of eligible studies included in this meta-analysis of parity and pancreatic cancer risk

From: Parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies

Author (Publication year)

Design and Study name

Country

Study period (follow-up years)

Age

N(case)

No. of participants/controls

Parity

OR (95%CI)

Factors investigated

Mesquita34 (1992)

PCC

Netherlands

1984–1988

35–79

176

487

1

Reference

Age, response status and life-time smoking of cigarettes

       

2

0.62 (0.23–1.69)

 
       

3

0.62 (0.22–1.74)

 
       

4+

0.51 (0.21–1.25)

 

Cantor35 (1993)

PCC

USA

1984–1987

40–85

169

821

1

Reference

Age, having a first degree relative with the same cancer and age at first birth

       

2

0.7 (0.4–1.3)

 
       

3

1.1 (0.6–2.1)

 
       

4

0.6 (0.3–1.3)

 
       

5+

0.5 (0.3–1.2)

 

Kalapothaki36 (1993)

HCC

Athens

1991–1992

-

66

66

Nulliparous

Reference

Age, hospital, past residence, years of schooling, cigarette smoking, diabetes melitus, as well as mutually (age at menarche, menopausal status and age at menopause)

       

Parous

0.39 (0.11–1.40)

 

Ji37 (1996)

PCC

China

1990–1993

30–74

451

1552

0–2

Reference

Age, income, education, smoking, green tea drinking, respondent status and BMI

       

3–4

1.33 (0.8–2.23)

 
       

≥5

1.88 (1.09–3.24)

 

Karlson38 (1998)

Nested CC

Swedish

-

Mean age, Case 52.7

1015

5073

1

Reference

Age

       

2

0.91 (0.75–1.1)

 
       

3

1.04 (0.84–1.29)

 
       

4

1.20 (0.91–1.59)

 
       

5+

1.16 (0.80–1.70)

 

Kreiger39 (2001)

PCC

Canada

1995–1996

20–75

52

233

0

Reference

Age, smoking status, BMI, tofu and dietary fat, age at menopause, oral contraceptive use, estrogen replacement therapy and age at menarche

       

1–2

0.69 (0.24–2.00)

 
       

3+

0.22 (0.07–0.65)

 

Skinner30 (2003)

Cohort Nurses' Health Study

USA

1976–1998 (22)

30–55

243

115474

0

Reference

Age, time period, cigarette smoking, diabetes, BMI and height

       

1–2

0.86 (0.55–1.36)

 
       

3–4

0.75 (0.48–1.17)

 
       

5+

0.58 (0.34–0.98)

 

Duell40 (2004)

PCC

USA

1995–1999

21–85

241

818

0

Reference

Age, education and smoking

       

1

1.3 (0.75–2.2)

 
       

2

1.0 (0.63–1.6)

 
       

3

1.3 (0.81–2.1)

 
       

4+

1.0 (0.63–1.7)

 

Teras18 (2005)

Cohort Cancer Prevention Study (CPS)-II

USA

1982–2000 (18)

60.5 ± 9.0

1959

387981

0

Reference

Age, race, smoking history, education, personal history of diabetes, BMI, height, exercise and family history of pancreatic cancer

       

1

0.99 (0.84–1.17)

 
       

2

0.96 (0.83–1.11)

 
       

3

1.10 (0.95–1.28)

 
       

4

0.96 (0.80–1.15)

 
       

5

0.78 (0.61–0.99)

 
       

6

0.88 (0.65–1.19)

 
       

7+

0.76 (0.57–1.03)

 

Silvera20 (2005)

Cohort National Breast Screening Study (NBSS)

Canada

1980–2000 (16.4)

40–59

187

89835

0

Reference

Age, cigarette smoking intensity, cigarette smoking duration, BMI, height, study left and randomization group (intervention vs control)

       

1–2

0.67 (0.43–1.06)

 
       

3–4

0.81 (0.53–1.24)

 
       

5+

1.05 (0.64–1.74)

 

Lin31 (2006)

Cohort The Japan Collaborative Cohort Study for Evaluation of Cancer Risk (the JACC study)

Japan

1988–1999 (10)

40–79

154

63273

0–1

Reference

Age, pack-years of smoking, history of diabetes, history of gallstone/cholecystitis and parity or age at first birth

       

2–3

0.74 (0.38–1.43)

 
       

4–5

0.84 (0.40–1.75)

 
       

≥6

0.80 (0.31–2.11)

 

Lo14 (2007)

HCC

Egypt

2001–2004

15–90

194

194

0–3

Reference

Age, residence and active smoking

       

4–6

1.3 (0.6–2.8)

 
       

7+

0.5 (0.2–1.3)

 

Prizment32 (2007)

Cohort Iowa Women's Health Study

USA

1986–2003 (18)

55–69

228

37459

0

Reference

Age

       

1–2

1.14 (0.69–1.88)

 
       

3–4

1.10 (0.67–1.81)

 
       

>4

1.09 (0.63–1.87)

 

Heuch26 (2008)

Cohort

Norway

1956–1998 (38)

32–74

449

63090

0

0.68 (0.45–1.04)

Age, birth cohort and breastfeeding

       

1

Reference

 
       

2

0.97 (0.69–1.35)

 
       

3

1.47 (1.03–2.09)

 
       

4

1.49 (0.98–2.26)

 
       

≥5

1.63 (1.01–2.64)

 

Steven16 (2009)

Cohort Million Women Study

UK

7.1

-

1182

995192

0

Reference

Age, region, socioeconomic status, smoking, body mass index and diabetes

       

1

0.88 (0.72–1.04)

 
       

2

0.78 (0.70–0.85)

 
       

3

0.81 (0.71–0.91)

 
       

4+

0.84 (0.72–0.96)

 

Zhang15 (2010)

HCC

USA

1976–2006

23–78

284

1096

0

Reference

Age, study left, year of interview and race

       

1–2

1.5 (1.0–3.2)

 
       

3–4

1.4 (0.9–2.2)

 
       

4+

1.5 (0.8–2.6)

 

Chang19 (2010)

Cohort

China

1978–2007 (29)

Age at first birth

243

1292462

1

Reference

Age at first childbirth, Marital status (married or unmarried), years of schooling (≤9 or ≥9 years) and birth place

       

2

0.69 (0.49–0.98)

 
       

3+

0.64 (0.44–0.93)

 

Lucenteforte26 (2011)

HCC

Italy

1983–1992 and 1991–2008

Median age Case (61) Control (58)

285

713

0

Reference

Study/left, age, education, area of residence, year of interview, history of diabetes and tobacco smoking

       

1

0.72 (0.4–1.16)

 
       

2

0.86 (0.55–1.33)

 
       

3

0.88 (0.53–1.46)

 
       

4+

0.46 (0.26–0.85)

 

Duell17 (2012)

Cohort European prospective investigation into cancer and nutrition (EPIC) cohort

Europen

1992–2006 (14)

35–70

304

328610

0

Reference

Age, left, smoking, education, alcohol consumption at baseline, red meat intake, BMI and diabetes history

       

1

1.01 (0.64–1.59)

 
       

2

1.03 (0.69–1.53)

 
       

3

0.92 (0.59–1.43)

 
       

4+

1.15 (0.71–1.85)

 

Lee33 (2013)

Cohort California Teachers Study

USA

1995–2009 (14)

Mean age 51.9

323

118164

1

Reference

Race/ethnicity, BMI, menopausal status HT use, age at menarche, smoking status and history of diabetes

       

2

0.98 (0.69–1.41)

 
       

3

0.88 (0.60–1.30)

 
       

4+

0.83 (0.55–1.29)

 
  1. Abbreviations: OR, odds ratio; CI, confidence interval; BMI, body mass index; HT, hormone replacement treatment; PCC, population-based case–control; HCC, hospital-based case–control.